Clone Robotics is a humanoid robotics company founded in 2021 that develops biomimetic androids powered by its proprietary Myofiber artificial muscle technology, using hydraulic actuation to replicate human anatomy. Its product lineup includes the Clone Hand, a commercially available dexterous robotic hand with human-like bone and muscle structure for teleoperation and manipulation tasks, and the Clone Alpha and Neoclone platforms, which are biomimetic humanoid systems built on the same artificial muscle approach. The company targets consumer household robotics with a planned ~$20,000 unit, positioning itself uniquely around muscle-based rather than electric-motor-based actuation.
The technologies for bringing humanoids to life